Cargando…

Depression and anxiety in cancer patient enrolled in clinical trials with serious adverse events

OBJECTIVE: Drug‐induced side effects, particularly serious adverse events (SAEs), often affect cancer patients enrolled in clinical trials. However, little is known about anxiety and depression in cancer patients who experienced SAEs. This study evaluated the prevalence of anxiety and depression in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Zhen, Wang, Chongwei, Sun, Yubei, Ma, Yan, Wang, Jumei, Xu, Fei, Xu, Xiaoling, Chen, Yin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	RESEARCH ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587935/ https://www.ncbi.nlm.nih.gov/pubmed/37723836 http://dx.doi.org/10.1002/cam4.6556

Ejemplares similares

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

Serious adverse events of older adults in nursing home and community intervention trials
por: Datta, Rupak, et al.
Publicado: (2017)

Serious Adverse Events Among SPRINT Trial Participants Taking Statins at Baseline
por: Huesch, Marco D.
Publicado: (2017)

Serious adverse events associated with yellow fever vaccine
por: de Menezes Martins, Reinaldo, et al.
Publicado: (2015)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Effects of Cognitive Behavioral Therapy for Depression and Anxiety, Response Rates and Adverse Events in Patients with Locoregional Advanced Nasopharyngeal Carcinoma
por: Liu, Feng, et al.
Publicado: (2021)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Association of Frailty Index with Clinical BPH Progression and Serious Adverse Events: the MTOPS Trial
por: Bauer, Scott, et al.
Publicado: (2021)

Serious adverse events and coping strategies of CAR-T cells in the treatment of malignant tumors
por: Chen, Xiujin, et al.
Publicado: (2022)

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
por: Awadzi, Kwablah
Publicado: (2003)

Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring
por: Donzelli, Alberto
Publicado: (2019)

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
por: James, Elizabeth C., et al.
Publicado: (2020)

Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles
por: Tang, Eve, et al.
Publicado: (2015)

Analysis of serious adverse events in a paediatric fast breathing pneumonia clinical trial in Malawi
por: Nkwopara, Evangelyn, et al.
Publicado: (2019)

Vaccine trials with no serious adverse reactions – estimation of upper 95% confidence intervals for likelihood of such events
por: Grech, Victor, et al.
Publicado: (2022)

Incorporation of text recognition into trial it systems to safeguard against enrolment of ineligible patients or inappropriate reporting of adverse events
por: Dennis, Martin, et al.
Publicado: (2013)

Association between depression and anxiety status of breast cancer patients before adjuvant chemotherapy and chemotherapy‐induced adverse events
por: Lv, Dan, et al.
Publicado: (2022)

Surveillance of serious adverse events following immunization in resource poor settings
por: Breugelmans, Gabrielle J, et al.
Publicado: (2011)

Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database
por: Kimura, Goji, et al.
Publicado: (2015)

A Cancer Patient’s Experience With a Rare But Serious Adverse Event
por: RayChaudhury, Amlan
Publicado: (2019)

An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir
por: Hosoda, Tomohiro, et al.
Publicado: (2019)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis
por: Yao, Yanhong, et al.
Publicado: (2021)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi
por: Ginsburg, Amy Sarah, et al.
Publicado: (2022)

Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo
por: Lemey, Gwen, et al.
Publicado: (2021)

Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review
por: Ouyang, Tao, et al.
Publicado: (2021)

Joint effects of recent stressful life events and adverse childhood experiences on perinatal comorbid anxiety and depression
por: Hou, Yanyan, et al.
Publicado: (2023)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
por: Lu, Jinmiao, et al.
Publicado: (2022)

Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting
por: Koen, Anthonet, et al.
Publicado: (2019)

Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)
por: Zhao, Ying, et al.
Publicado: (2022)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
por: Duprey, Matthew S., et al.
Publicado: (2019)

Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers
por: Williams, S. Elizabeth, et al.
Publicado: (2013)

Serious adverse event: late neurotropic disease associated with yellow fever vaccine
por: de Oliveira, Henrique Souza Barros, et al.
Publicado: (2020)

Cardiac and vascular serious adverse events following tixagevimab–cilgavimab – Author's reply
por: Maselkar, Sheetal, et al.
Publicado: (2023)

A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017)

Serious adverse events and compensation in registration trials: a review of data from a Japanese university hospital
por: Watanabe, Miho, et al.
Publicado: (2014)

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
por: Fraiman, Joseph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n2jd42jenp8i8bmp7lkbb3icle